CJC-1295 DAC 10mg
$144.00
CJC-1295 DAC 10mg is a high-concentration synthetic analog of growth hormone-releasing hormone (GHRH) designed for large-scale institutional and academic research. Each vial contains 10mg of high-purity CJC-1295 coupled with the Drug Affinity Complex (DAC), engineered to significantly extend the peptide’s half-life for longitudinal metabolic studies. This research-grade compound is lyophilized to ensure maximum structural integrity and consistent experimental results.
| Property | Specification |
|---|---|
| Compound | CJC-1295 with DAC (tetrasubstituted GHRH analog) |
| Vial concentration | 10mg single compound |
| Base peptide formula | C₁₆₅H₂₆₉N₄₇O₄₆ (approx., base peptide) |
| Class | Long-acting GHRH receptor agonist |
| Purity | >99% (HPLC & MS verified) |
| Format | White lyophilized powder |
| Storage | -20°C for long-term stability |
CJC-1295 DAC 10mg for Sale | 99% Pure High-Capacity GHRH Analog (Albumin-Bound)
Run a study long enough and a small vial becomes a logistics problem. Every re-order is a new lot, a new COA to reconcile, a fresh variable creeping into data you wanted to keep clean. That’s the quiet case for CJC-1295 DAC 10mg — not that it’s a different molecule from the 5mg, but that it lets a lab hold one consistent batch across an extended timeline. And this compound is built for extended timelines: in the foundational human trial, repeated dosing kept IGF-1 elevated above baseline for up to 28 days (Teichman et al., JCEM, 2006).
CJC-1295 DAC 10mg is the high-capacity, research-grade format of the long-acting GHRH analog — a tetrasubstituted peptide carrying the albumin-binding Drug Affinity Complex, lyophilized for stability and sized for scale. If you’re the researcher who keeps running out mid-protocol, this vial was made with you in mind.
Scope, up front: supplied for in-vitro laboratory and analytical research by qualified professionals. It’s an investigational compound — not FDA-approved, not a medicine, and nothing below is a use protocol or clinical advice.
Why Reach for the 10mg?
The choice between 5mg and 10mg isn’t really about the peptide — it’s about the shape of your research. The high-capacity vial makes sense when:
- You’re running longitudinal studies where a single consistent lot matters more than a small starter quantity.
- Your protocol involves repeated or high-frequency administration across weeks, and steady-state accumulation is part of what you’re measuring.
- You want to minimize batch-to-batch variance by drawing from one verified source rather than stitching together several re-orders.
- You’re supporting multi-arm or institutional-scale work where volume is a practical necessity.
For single-arm pilots or dose-finding, the 5mg is usually the cleaner call. For everything longer, 10mg earns its keep.
Where CJC-1295 DAC Fits in Research
This is a duration tool first and foremost. The applications that draw researchers to it:
| Research Focus | What’s Being Investigated |
|---|---|
| Sustained pituitary stimulation | Days-long GHRH-receptor activation from infrequent administration |
| Steady-state IGF-1 dynamics | How IGF-1 accumulates and holds under repeated long-acting dosing |
| GH pulsatility under load | Whether somatostatin feedback preserves natural pulsing during sustained stimulation |
| Secretagogue combination models | Pairing with GHRP-class peptides such as Ipamorelin |
| Longitudinal PK/PD | Pharmacokinetic and pharmacodynamic behavior across extended timelines |
The Mechanism, Briefly
CJC-1295 is a modified GHRH(1–29) fragment, altered at four positions to resist enzymatic breakdown. Left alone, that peptide still clears in roughly half an hour. The Drug Affinity Complex is what transforms it: after injection, the DAC forms a covalent bond with serum albumin, extending the half-life to about 5.8–8.1 days (Teichman et al., 2006; PMID 16352683).
It works upstream — binding GHRH receptors on the anterior pituitary and signaling through the Gs/cAMP/PKA cascade to prompt the gland’s own GH release (Superpower guide, 2026). Because the stimulation runs through native receptors, somatostatin still applies the brakes, so pulsatile secretion is preserved rather than flattened. That’s a genuinely different profile from administering growth hormone directly — and it’s central to why the compound is studied the way it is.
How the 10mg Compares
| Format | Half-Life | Best For |
|---|---|---|
| CJC-1295 DAC 10mg | ~5.8–8.1 days | Longitudinal, high-frequency, or multi-arm studies |
| CJC-1295 DAC 5mg | ~5.8–8.1 days | Single-arm pilots, dose-finding, standard scale |
| CJC-1295 no-DAC (Mod-GRF 1-29) | ~30 min | Short-pulse studies; same base peptide, no albumin binding |
| Sermorelin / Tesamorelin | ~10–38 min | Shorter-acting GHRH analogs with different regulatory status |
The 5mg and 10mg are chemically identical — this is purely a scale decision. The bigger fork in the road is DAC versus no-DAC, which is the difference between an eight-day half-life and a thirty-minute one.
Specifications and Batch Control
What’s in the vial:
| Property | Specification |
|---|---|
| Compound | CJC-1295 with DAC (tetrasubstituted GHRH analog) |
| Vial concentration | 10mg single compound |
| Base peptide formula | C₁₆₅H₂₆₉N₄₇O₄₆ (approx., base peptide) |
| Class | Long-acting GHRH receptor agonist |
| Purity | >99% (HPLC & MS verified) |
| Format | White lyophilized powder |
| Storage | -20°C for long-term stability |
How each lot is verified:
| Control | Standard |
|---|---|
| Purity | 99%+ guaranteed via HPLC and Mass Spectrometry |
| Lyophilization | Advanced freeze-drying to protect structure and extend shelf life |
| Documentation | Batch-specific COA included with every order |
| Synthesis | Precise sequencing and verified DAC attachment for reproducibility |
Handling the 10mg in the Lab
More material means more draws from one vial, which makes disciplined aliquoting even more important here than with a small format. Laboratory handling steps for qualified researchers:
| Step | What to Do |
|---|---|
| Warm | Let the sealed vial reach room temperature before opening — prevents condensation |
| Add solvent | Trickle bacteriostatic or sterile water down the inner glass wall, never onto the powder |
| Mix | Swirl gently until clear; shaking stresses the peptide |
| Aliquot | Divide into single-use portions immediately — with 10mg, freeze-thaw discipline protects the whole vial |
| Store | Powder frozen at -20°C; reconstituted solution at 2–8°C, out of the light, used within a few weeks |
Discard anything that turns cloudy or discolored. When you’re drawing from a larger vial repeatedly, that visual check before each use is cheap insurance.
CJC-1295 DAC 10mg for Sale — Shipping Worldwide
Our research-grade CJC-1295 DAC 10mg ships as HPLC/MS-verified, COA-backed lyophilized vials — sealed, documented, and ready for the bench. We fulfill orders for laboratories and independent researchers across the highest-demand markets:
- 🇺🇸 USA — fast domestic dispatch
- 🇨🇦 Canada — reliable cross-border delivery
- 🇩🇪 Germany (Deutschland) — trusted EU logistics
- 🇫🇷 France — secure European shipping
When you buy CJC-1295 DAC in the high-capacity format, you’re really buying consistency — one lot, one COA, one fewer variable across a long study. That’s what makes bulk worth it.
FAQs about CJC-1295 DAC 10mg
1. What is CJC-1295 DAC 10mg? A high-capacity 10mg vial of CJC-1295 with the Drug Affinity Complex — a long-acting GHRH analog supplied as a lyophilized powder for growth-hormone-axis research.
2. What’s the difference between the 5mg and 10mg? Only the quantity. Same peptide, same purity, same half-life — the 10mg simply gives you more material for longitudinal, high-frequency, or multi-arm work. Pick 5mg for pilots and dose-finding.
3. What does the DAC do? It binds the peptide to serum albumin after injection, stretching the half-life from about 30 minutes to roughly 8 days. Sustained action is the entire reason the DAC form exists.
4. Why does the 10mg suit longitudinal studies? Because repeated dosing drives IGF-1 toward steady state — held above baseline up to 28 days in trials — and a single large lot keeps batch variance out of a long dataset.
5. How does CJC-1295 raise growth hormone? It activates GHRH receptors on the anterior pituitary through the Gs/cAMP/PKA pathway, prompting the gland’s own GH release, which preserves natural pulsatility and somatostatin feedback.
6. What did the Teichman trial show? In 33 healthy adults, single doses raised GH 2–10 fold for 6+ days and IGF-1 1.5–3 fold for 9–11 days; repeated dosing sustained IGF-1 up to 28 days.
7. Is CJC-1295 FDA approved? No. It’s classified as an FDA 503A Category 2 substance as of April 2026 and is barred from compounding. This product is strictly for laboratory research.
8. Is CJC-1295 prohibited in sport? Yes — WADA lists it under S2 (peptide hormones and growth factors), banned in and out of competition.
9. Does buying 10mg change how it’s stored? No — same rules: powder at -20°C, reconstituted solution at 2–8°C away from light, used within a few weeks. But with more draws per vial, careful aliquoting matters more.
10. How is CJC-1295 DAC reconstituted? Warm the vial, add bacteriostatic or sterile water down the glass wall, swirl gently, then aliquot. The handling table above lays it out.
11. What purity should CJC-1295 DAC be? Aim for 99%+ confirmed by HPLC and Mass Spectrometry, with a lot-specific COA. Ours meets that on every batch.
12. Where can I buy CJC-1295 DAC 10mg internationally? GLP1 Peptides ships research-grade, COA-verified CJC-1295 DAC 10mg to the USA, Canada, Germany, and France in sealed lyophilized vials. See the shipping section above.







Reviews
There are no reviews yet.